LLY vs RGEN
Eli Lilly and Company vs Repligen — AI-powered side-by-side comparison
| Metric | LLY | RGEN |
|---|---|---|
| AI Score | 56 | 62 |
| Price | $1,148.86 | $141.09 |
| P/E Ratio | 40.73× | 190.55× |
| ROE | 0.8% | 0.0% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 0.5% |
| Debt / Equity | 1.39× | 0.33× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 37.7 | 50.9 |
| Beta | 0.506 | 1.06 |
| Expected Upside | — | +5.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
LLY Full Analysis
RGEN Full Analysis